Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade.

Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade.

While neurohumoral antagonists improve outcomes in heart failure (HF), cardiac remodeling and dysfunction progress and outcomes remain poor. Therapies superior or additive to standard HF therapy are needed. Pharmacologic mTOR inhibition by rapamycin attenuated adverse cardiac remodeling and dysfunct...

Full description

Bibliographic Details
Main Authors: Kalkidan Bishu, Ozgur Ogut, Sudhir Kushwaha, Selma F Mohammed, Tomohito Ohtani, Xiaolei Xu, Frank V Brozovich, Margaret M Redfield
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3849273?pdf=render

Internet

http://europepmc.org/articles/PMC3849273?pdf=render

Similar Items